US FDA approves Merck immunotherapy/chemo combo for lung cancer - Reuters

U.S. News & World Report

US FDA approves Merck immunotherapy/chemo combo for lung cancer Reuters May 10 Merck & Co said on Wednesday U.S. health regulators approved its Keytruda in combination with chemotherapy for previously untreated advanced lung cancer, solidifying the drugmaker's lead position in the field of medicines that help the immune ... FDA Approves Combining Merck's Keytruda With Chemotherapy in Lung Cancer PatientsFox Business all 10 news articles »

from Health - Google News http://ift.tt/2pmk0Cv